Biliary atresia is a rare but serious liver disease that primarily affects infants, leading to bile duct blockage and progressive liver damage. Without timely intervention, this condition can cause liver failure, which often necessitates a liver transplant to save the patient's life. Liver transplantation remains the definitive treatment for end-stage liver failure caused by biliary atresia. The procedure involves replacing the damaged liver with a healthy donor liver, restoring liver function and significantly improving the patient’s quality of life. Medical advancements have improved transplant success rates, but the waiting period can be challenging, as highlighted by many patients and families eagerly awaiting transplantation. Early diagnosis is critical for managing biliary atresia. Symptoms such as jaundice, dark urine, pale stool, and an enlarged liver in infants should prompt immediate medical evaluation. Treatments prior to transplantation may include surgical interventions like the Kasai procedure, which can improve bile flow but is not always sufficient. Post-transplant care is equally important, involving lifelong monitoring and immunosuppressive therapy to prevent organ rejection. Support groups and counseling services can provide emotional and psychological support to patients and families during the transplant journey. Awareness about liver diseases and the importance of liver transplantation can lead to earlier diagnoses and better outcomes. Ongoing research continues to explore improved therapies and organ preservation techniques, promising a better future for those affected by biliary atresia and liver failure.